It is worth noting that improving levels of DCV cargos (i.e., BDNF and somatostatin) partially recover AD-altered networks, preventing cognitive deficits and favoring Aβ clearance (Saito et al., 2005; Nagahara et al., 2009; Zhang et al., 2015). This evidence concerns the gene BDNF and Alzheimer disease.